Home > News & Events

News & Events

CPRIT awards more than $103 million in cancer grants; expands rural clinical trials

Published: 05/20/2026

(AUSTIN) The governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) met today and approved more than $103 million in 69 new cancer research and innovation grants for institutions and companies across Texas. The grants expand rural clinical trials, support core facilities, fund childhood and adolescent cancer survivorship research and help recruit and train the next generation of Texas scientists.  These awards reflect CPRIT’s comprehensive approach to accelerating cancer cures and treatments and reducing the burden of cancer for Texans and Texas families.

CPRIT approves more than $15 million in new funding for cancer research and recruitment

Published: 02/18/2026

(AUSTIN) The governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) met in Austin today and approved more than $15 million in CPRIT Scholar recruitment grants to bring five new cancer scientists to four Texas research institutions.

2025 CPRIT Annual Report is Available Now

Published: 02/02/2026

CPRIT 2025 Annual Report Now Available

(AUSTIN, TX) CPRIT announces the release of the 2025 CPRIT Annual Report, a web-based review of our sixteenth year as the state’s cancer-fighting agency.

Created by the Texas Legislature with overwhelming bipartisan support and approved by Texans in two statewide votes, CPRIT is a $6 billion investment in groundbreaking research to prevent, diagnose, treat, and survive cancer.  Through CPRIT, Texas is the second largest public funder of cancer research in the U.S., following only the National Cancer Institute.

 

CPRIT approves almost $154 million in new cancer research and prevention awards, surpasses $4 billion total

Published: 11/19/2025

(AUSTIN) The governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) met in Austin today and approved 73 grants totaling almost $154 million. With today’s vote, CPRIT’s total investment in cancer prevention and research tops $4 billion—more than any other state in the nation. CPRIT, which marked the 18th anniversary of the statewide vote that launched the agency this month, stands as the second-largest funder of cancer research in the country after the National Cancer Institute. 

CPRIT names new Chief Prevention Officer

Published: 10/07/2025

(AUSTIN) The Cancer Prevention and Research Institute of Texas (CPRIT) is proud to announce Ruth Rechis, Ph.D., as our new Chief Prevention Officer.  Dr. Rechis comes to CPRIT from The University of Texas MD Anderson Cancer Center in Houston, where she served as Executive Director of the Cancer Prevention and Control Platform which leads initiatives focused on place-based investments in health, health systems strengthening, and impact evaluation.  Previously, she was part of the executive leadership team at the Livestrong Foundation in Austin where she worked for over a decade. The Livestrong Foundation was vital to the successful legislative effort and passage of the constitutional amendment that created CPRIT in 2007. 

CPRIT Approves more than $27 Million In Grants for Cancer Research in Texas

08/20/2025

AUSTIN, TX – The Cancer Prevention and Research Institute of Texas (CPRIT) today announced the approval of 15 new grants totaling more than $27 million, reinforcing Texas’ position as a national leader in cancer research and innovation. These investments support faculty recruitment, research infrastructure, and high-impact scientific projects at institutions across the state.  The CPRIT Oversight Committee approved the grants at their quarterly meeting in Austin. 

“CPRIT advanced the fight against cancer again today,” said CEO Kristen Doyle. “These grants not only fund pioneering research but also invest in critical life science infrastructure that will lead to tomorrow’s cancer treatments and cures—right here in Texas.” 

Our Grantees in the News

Media Contact

Mark Loeffler
Communications Director

Phone: 512-305-8483
Email: [email protected]